Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.58 $5.85 Wednesday, 8th May 2024 CTMX stock ended at $4.19. This is 2.95% more than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 10.95% from a day low at $3.79 to a day high of $4.21.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Aug 09, 2016 $11.18 $11.46 $11.00 $11.07 85 600
Aug 08, 2016 $11.59 $11.68 $10.96 $11.24 88 700
Aug 05, 2016 $10.64 $11.57 $10.64 $11.37 93 300
Aug 04, 2016 $10.40 $10.62 $10.25 $10.58 102 000
Aug 03, 2016 $9.84 $10.55 $9.84 $10.46 33 200
Aug 02, 2016 $10.40 $10.60 $10.03 $10.14 65 400
Aug 01, 2016 $10.14 $10.29 $9.95 $10.25 42 200
Jul 29, 2016 $10.02 $10.30 $9.81 $10.06 67 000
Jul 28, 2016 $10.35 $10.54 $9.99 $10.02 69 400
Jul 27, 2016 $10.10 $10.43 $9.92 $10.42 151 000
Jul 26, 2016 $10.45 $10.54 $9.92 $10.00 158 700
Jul 25, 2016 $10.55 $10.78 $10.29 $10.34 77 000
Jul 22, 2016 $10.50 $10.75 $10.42 $10.50 46 200
Jul 21, 2016 $10.75 $10.90 $10.52 $10.55 29 200
Jul 20, 2016 $10.25 $10.84 $10.19 $10.75 71 700
Jul 19, 2016 $10.66 $11.00 $10.28 $10.33 58 200
Jul 18, 2016 $10.66 $10.83 $10.48 $10.65 41 600
Jul 15, 2016 $10.59 $10.75 $9.98 $10.69 47 800
Jul 14, 2016 $11.00 $11.00 $10.18 $10.43 43 500
Jul 13, 2016 $11.15 $11.15 $10.33 $10.55 119 200
Jul 12, 2016 $10.70 $11.30 $10.57 $11.10 103 100
Jul 11, 2016 $10.76 $10.95 $10.50 $10.61 98 700
Jul 08, 2016 $10.29 $10.82 $10.29 $10.71 74 300
Jul 07, 2016 $10.17 $10.42 $10.10 $10.20 41 200
Jul 06, 2016 $9.92 $10.42 $9.77 $10.16 36 400
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT